$SNGX
SOLIGENIX, INC.

2023 Q1 Form 10-K Financial Statement

#000155837023005304 Filed on March 31, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $257.2K $366.1K $948.9K
YoY Change 36.75% 32.8% 15.12%
Cost Of Revenue $226.0K $135.9K $550.8K
YoY Change 145.13% -42.35% -24.4%
Gross Profit $31.14K $230.2K $398.1K
YoY Change -67.51% 476.22% 316.29%
Gross Profit Margin 12.11% 62.88% 41.95%
Selling, General & Admin $1.235M $1.442M $6.693M
YoY Change -51.59% -32.17% 38.08%
% of Gross Profit 3967.44% 626.58% 1681.26%
Research & Development $946.5K $2.358M $7.944M
YoY Change -45.82% -3.2% -5.31%
% of Gross Profit 3039.54% 1024.24% 1995.56%
Depreciation & Amortization $1.790K $3.020K $24.56K
YoY Change -78.26% -60.0% -28.11%
% of Gross Profit 5.75% 1.31% 6.17%
Operating Expenses $2.182M $3.800M $14.64M
YoY Change -49.24% -16.7% 10.58%
Operating Profit -$2.151M -$3.570M -$14.24M
YoY Change -48.83% -21.06% 8.36%
Interest Expense -$103.6K -$185.4K -$822.6K
YoY Change -66.57% -20.95% -8.8%
% of Operating Profit
Other Income/Expense, Net -$56.62K $1.810K -$714.4K
YoY Change -61.33% -96.58% 159.93%
Pretax Income -$2.207M -$3.754M -$14.95M
YoY Change -49.25% -20.2% 11.46%
Income Tax -$1.161M $0.00 -$1.155M
% Of Pretax Income
Net Earnings -$1.046M -$3.754M -$13.80M
YoY Change -75.95% -20.2% 9.94%
Net Earnings / Revenue -406.76% -1025.37% -1454.12%
Basic Earnings Per Share -$0.36 -$4.81
Diluted Earnings Per Share -$0.36 -$1.30 -$4.81
COMMON SHARES
Basic Shares Outstanding 2.924M 43.23M 2.871M
Diluted Shares Outstanding 2.915M 2.871M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.27M $13.36M $13.36M
YoY Change -55.12% -48.7% -48.7%
Cash & Equivalents $10.27M $13.36M $13.36M
Short-Term Investments
Other Short-Term Assets $213.3K $274.2K $274.2K
YoY Change -39.68% -3.07% -3.07%
Inventory
Prepaid Expenses $213.3K $274.2K
Receivables $218.0K $115.1K $115.1K
Other Receivables $24.77K $104.2K $104.2K
Total Short-Term Assets $10.72M $13.85M $13.85M
YoY Change -54.32% -47.86% -47.86%
LONG-TERM ASSETS
Property, Plant & Equipment $16.70K $18.48K $359.5K
YoY Change -39.7% -16.83% 180.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $49.12K $67.10K $67.10K
YoY Change 1167.61% 765.81% -61.0%
Total Long-Term Assets $379.9K $426.6K $426.6K
YoY Change 89.56% 42.0% 42.0%
TOTAL ASSETS
Total Short-Term Assets $10.72M $13.85M $13.85M
Total Long-Term Assets $379.9K $426.6K $426.6K
Total Assets $11.10M $14.28M $14.28M
YoY Change -53.11% -46.86% -46.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.769M $3.866M $3.866M
YoY Change -38.71% 32.14% 32.14%
Accrued Expenses $2.451M $2.308M $2.753M
YoY Change -5.45% -21.94% -18.19%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $6.000M $9.898M $9.898M
YoY Change
Total Short-Term Liabilities $11.38M $16.52M $16.52M
YoY Change 57.49% 162.54% 162.54%
LONG-TERM LIABILITIES
Long-Term Debt $2.908M $0.00 $0.00
YoY Change -70.53% -100.0% -100.0%
Other Long-Term Liabilities $204.3K $233.6K $233.6K
YoY Change
Total Long-Term Liabilities $3.112M $233.6K $233.6K
YoY Change -68.46% -97.63% -97.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.38M $16.52M $16.52M
Total Long-Term Liabilities $3.112M $233.6K $233.6K
Total Liabilities $14.49M $16.75M $16.75M
YoY Change -15.22% 3.74% 3.74%
SHAREHOLDERS EQUITY
Retained Earnings -$220.6M -$219.6M
YoY Change 5.0% 6.71%
Common Stock $2.930K $2.909K
YoY Change -93.18% -93.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.387M -$2.471M -$2.471M
YoY Change
Total Liabilities & Shareholders Equity $11.10M $14.28M $14.28M
YoY Change -53.11% -46.86% -46.86%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$1.046M -$3.754M -$13.80M
YoY Change -75.95% -20.2% 9.94%
Depreciation, Depletion And Amortization $1.790K $3.020K $24.56K
YoY Change -78.26% -60.0% -28.11%
Cash From Operating Activities -$2.166M -$3.627M -$12.65M
YoY Change -33.12% 18.71% 7.75%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $13.07K
YoY Change -100.0% -100.0% -210.86%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$13.07K
YoY Change -100.0% -100.0% 10.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -931.6K 76.82K 76.82K
YoY Change -69.37% -99.6%
NET CHANGE
Cash From Operating Activities -2.166M -3.627M -12.65M
Cash From Investing Activities 0.000 0.000 -13.07K
Cash From Financing Activities -931.6K 76.82K 76.82K
Net Change In Cash -3.094M -3.550M -12.68M
YoY Change -2.35% 26.06% -272.17%
FREE CASH FLOW
Cash From Operating Activities -$2.166M -$3.627M -$12.65M
Capital Expenditures $0.00 $0.00 $13.07K
Free Cash Flow -$2.166M -$3.627M -$12.66M
YoY Change -32.91% 19.17% 7.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.81
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.69
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2871345
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2675488
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000812796
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2908578
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2858244
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-14778
CY2022 dei Entity Registrant Name
EntityRegistrantName
SOLIGENIX, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1505029
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
29 EMMONS DRIVE
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE B-10
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
PRINCETON
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
08540
CY2022 dei City Area Code
CityAreaCode
609
CY2022 dei Local Phone Number
LocalPhoneNumber
538-8200
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022 dei Trading Symbol
TradingSymbol
SNGX
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
25734915
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2924491
CY2022 dei Auditor Firm
AuditorFirmId
274
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13359615
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26043897
CY2022Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
115130
CY2021Q4 us-gaap Grants Receivable Current
GrantsReceivableCurrent
138889
CY2022Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
104198
CY2021Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
103832
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
274209
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
282903
CY2022Q4 us-gaap Assets Current
AssetsCurrent
13853152
CY2021Q4 us-gaap Assets Current
AssetsCurrent
26569521
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
22777
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
22777
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
114766
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
167848
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18481
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22220
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
20206
CY2021Q4 us-gaap Deferred Costs
DeferredCosts
20266
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340987
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
106155
CY2022Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
24114
CY2021Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
121238
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7750
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
347546
CY2022Q4 us-gaap Assets
Assets
14279717
CY2021Q4 us-gaap Assets
Assets
26869927
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3865796
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2925544
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2307746
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2956545
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
336692
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
302936
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
108948
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
106151
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
102309
CY2022Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
9897691
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16516873
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6291176
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
143847
CY2022Q4 us-gaap Convertible Debt
ConvertibleDebt
0
CY2021Q4 us-gaap Convertible Debt
ConvertibleDebt
9856153
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
233627
CY2022Q4 us-gaap Liabilities
Liabilities
16750500
CY2021Q4 us-gaap Liabilities
Liabilities
16147329
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
43
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
300000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
350000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2908578
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2858244
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2909
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2859
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
217064964
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
216442904
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
24747
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
41942
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-219563446
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-205765107
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2470826
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10722598
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14279717
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26869927
CY2022 us-gaap Revenues
Revenues
948911
CY2021 us-gaap Revenues
Revenues
824268
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
550822
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
728640
CY2022 us-gaap Gross Profit
GrossProfit
398089
CY2021 us-gaap Gross Profit
GrossProfit
95628
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7944089
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8185850
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6692904
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5008738
CY2022 us-gaap Operating Expenses
OperatingExpenses
14636993
CY2021 us-gaap Operating Expenses
OperatingExpenses
13194588
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-14238904
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-13098960
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
421584
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-30549
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-39361
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-822611
CY2021 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-904502
CY2022 sngx Uk Research And Development Incentives
UkResearchAndDevelopmentIncentives
-132869
CY2021 sngx Uk Research And Development Incentives
UkResearchAndDevelopmentIncentives
-174770
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5921
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30754
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-714370
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-316755
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14953274
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13415715
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1154935
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-864742
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13798339
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12550973
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.81
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.69
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2871345
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2675488
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13798339
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-12550973
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17195
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
66279
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13815534
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12484694
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3741828
CY2021 sngx Stock Issued During Period Value Pursuant To Market Sales Agreement
StockIssuedDuringPeriodValuePursuantToMarketSalesAgreement
19705647
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
655156
CY2021 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
27500
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25835
CY2021 sngx Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
79
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
361559
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
66279
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-12550973
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10722598
CY2022 sngx Stock Issued During Period Value Pursuant To Market Sales Agreement
StockIssuedDuringPeriodValuePursuantToMarketSalesAgreement
79354
CY2022 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2593
CY2022 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
43
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
212003
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
333389
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17195
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13798339
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2470826
CY2022 us-gaap Profit Loss
ProfitLoss
-13798339
CY2021 us-gaap Profit Loss
ProfitLoss
-12550973
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
24562
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
34161
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
112714
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
116290
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
333389
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
361559
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
212003
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
27500
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
41538
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
41926
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
421584
CY2022 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-23759
CY2021 us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-64885
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-8694
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
57430
CY2022 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-73374
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-205237
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-111122
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-116290
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
396651
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1127259
CY2022 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
33756
CY2021 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-572160
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12649021
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11739620
CY2022 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
13073
CY2021 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
11789
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13073
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11789
CY2022 sngx Proceeds From Issuance Of Common Stock Pursuant To Market Sales Agreement
ProceedsFromIssuanceOfCommonStockPursuantToMarketSalesAgreement
79354
CY2021 sngx Proceeds From Issuance Of Common Stock Pursuant To Market Sales Agreement
ProceedsFromIssuanceOfCommonStockPursuantToMarketSalesAgreement
19705647
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2533
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
621899
CY2021 sngx Proceeds From Exercise Of Warrants
ProceedsFromExerciseOfWarrants
-79
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25835
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
45512
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
6149
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
76821
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19058001
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-99009
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60642
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12684282
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7367234
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26043897
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18676663
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13359615
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26043897
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
16043
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
7727
CY2022 us-gaap Interest Paid Net
InterestPaidNet
857411
CY2021 us-gaap Interest Paid Net
InterestPaidNet
668715
CY2022 sngx Operating Lease Paid
OperatingLeasePaid
133300
CY2021 sngx Operating Lease Paid
OperatingLeasePaid
133300
CY2021 sngx Financing Lease Paid
FinancingLeasePaid
6408
CY2022 sngx Noncash Or Part Noncash Deferred Issuance Cost Reclassified To Additional Paid In Capital
NoncashOrPartNoncashDeferredIssuanceCostReclassifiedToAdditionalPaidInCapital
60
CY2021 sngx Noncash Or Part Noncash Deferred Issuance Cost Reclassified To Additional Paid In Capital
NoncashOrPartNoncashDeferredIssuanceCostReclassifiedToAdditionalPaidInCapital
33257
CY2022 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
43
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-219563446
CY2022 sngx Working Capital Increase Decrease
WorkingCapitalIncreaseDecrease
2663721
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-13798339
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12649021
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13359615
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26043897
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12684282
CY2022 sngx Percentage Change In Cash And Cash Equivalents
PercentageChangeInCashAndCashEquivalents
0.49
CY2022Q4 sngx Working Capital Carrying Value
WorkingCapitalCarryingValue
2663721
CY2021Q4 sngx Working Capital Carrying Value
WorkingCapitalCarryingValue
20278345
CY2021 sngx Working Capital Increase Decrease
WorkingCapitalIncreaseDecrease
-22942066
CY2021 sngx Working Capital Percentage Increase Decrease
WorkingCapitalPercentageIncreaseDecrease
1.13
CY2023Q1 sngx Stockholders Equity Note Stock Split Fractional Shares Issued Number Shares
StockholdersEquityNoteStockSplitFractionalSharesIssuedNumberShares
0
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Reclassifications</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Certain amounts in the statement of operations for the year ended December 31, 2021 have been reclassified to conform to the current year presentation.</p>
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0113
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
133300
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
133300
CY2019Q2 us-gaap Development Costs
DevelopmentCosts
46500
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
25%
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
25%
CY2022 sngx Share Based Compensation Arrangement Service Period
ShareBasedCompensationArrangementServicePeriod
P3Y
CY2022 sngx Sharebased Compensation Expiration Period
SharebasedCompensationExpirationPeriod
P10Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.84
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.84
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.87
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.87
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0112
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0451
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0027
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-30549
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-39361
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1154935
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-864742
CY2021Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2022Q4 sngx Research And Development Incentive Receivable
ResearchAndDevelopmentIncentiveReceivable
128000
CY2021Q4 sngx Research And Development Incentive Receivable
ResearchAndDevelopmentIncentiveReceivable
225000
CY2021Q4 sngx Incentives
Incentives
225070
CY2022 sngx Uk Research And Development Incentive
UKResearchAndDevelopmentIncentive
24963
CY2022 sngx Additional2019 Incentive Earned
Additional2019IncentiveEarned
107906
CY2022 sngx Uk Research And Development Incentives Cash Receipt
UKResearchAndDevelopmentIncentivesCashReceipt
-209166
CY2022 sngx Foreign Currency Translation
ForeignCurrencyTranslation
-20461
CY2022Q4 sngx Incentives
Incentives
128312
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
134892
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
134892
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.043
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-864742
CY2022 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.031
CY2021 us-gaap Effective Income Tax Rate Reconciliation Deductions
EffectiveIncomeTaxRateReconciliationDeductions
0.013
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.004
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.006
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
355542
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
525470
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates and Assumptions</span></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions such as the fair value of warrants and stock options and to accrue for clinical trials in process that affect the reported amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340987
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
106155
CY2022Q4 sngx Lease Liability Operating Current And Noncurrent
LeaseLiabilityOperatingCurrentAndNoncurrent
342575
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
106151
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
133817
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
136917
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
116250
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
386984
CY2022Q4 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.0847
CY2022Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P34M
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
222445
CY2021 sngx Operating Lease Right Of Use Asset Reduction Amortization
OperatingLeaseRightOfUseAssetReductionAmortization
-116290
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
106155
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
347546
CY2022 sngx Operating Lease Right Of Use Asset Reduction Amortization
OperatingLeaseRightOfUseAssetReductionAmortization
-112714
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
340987
CY2020Q4 sngx Lease Liability Operating Current And Noncurrent
LeaseLiabilityOperatingCurrentAndNoncurrent
222441
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
116290
CY2021Q4 sngx Lease Liability Operating Current And Noncurrent
LeaseLiabilityOperatingCurrentAndNoncurrent
106151
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
347546
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
111122
CY2022Q4 sngx Lease Liability Operating Current And Noncurrent
LeaseLiabilityOperatingCurrentAndNoncurrent
342575
CY2022 sngx Effectiveincometaxratereconciliationexpirationoftaxattributes
Effectiveincometaxratereconciliationexpirationoftaxattributes
0.091
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.024
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.076
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
0.002
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Foreign
EffectiveIncomeTaxRateReconciliationTaxCreditsForeign
0.001
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
-0.039
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1884117
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2625779
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
423629
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
330766
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2307746
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2956545
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4634438
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4295638
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
2021349
CY2022Q4 sngx Total Long Term
TotalLongTerm
10951425
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2021 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0
CY2022 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0
CY2021 us-gaap Foreign Income Tax Expense Benefit Continuing Operations
ForeignIncomeTaxExpenseBenefitContinuingOperations
0
CY2022 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-1154935
CY2021 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
-864742
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1154935
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27252000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
28065000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
8837000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
8605000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
285000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
264000
CY2022Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1696000
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
1953000
CY2022Q4 sngx Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
1832000
CY2022Q4 sngx Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
96000
CY2021Q4 sngx Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
30000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
39998000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
38917000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39902000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
38887000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
96000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
30000
CY2022Q4 sngx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
96000
CY2021Q4 sngx Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
30000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
96000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
30000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
124000000.0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
13200000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1400000
CY2022Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
8800000
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
1154935
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
864742
CY2021 sngx Effectiveincometaxratereconciliationexpirationoftaxattributes
Effectiveincometaxratereconciliationexpirationoftaxattributes
0.049
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.068
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.196
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.077
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.064
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
350000
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5377
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
9.30
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6411
CY2022Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
7.80
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3664
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
13.65
CY2022Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1667
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
7.20
CY2022Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5129
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
9.75
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2018
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.81
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1667
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
16.50
CY2022 sngx Share Based Compensation Arrangement By Share Based Payment Award Number Of Equity Programs
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfEquityPrograms
4
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
128858
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
44.41
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
32925
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
13.68
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
15982
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
54.61
CY2021 sngx Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
2787
CY2021 sngx Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
11.70
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2018
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.81
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140996
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.12
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
55730
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.85
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3908
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
107.83
CY2022 sngx Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
545
CY2022 sngx Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice
11.70
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
192273
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.56
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
333389
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
361559
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
427000
CY2022 sngx Payment For Commitment Milestones
PaymentForCommitmentMilestones
13200000
CY2022 sngx Percentage Of Sub License Income Royalties
PercentageOfSubLicenseIncomeRoyalties
0.15
CY2022Q4 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
6200
CY2022Q2 sngx Lease Rental Per Month
LeaseRentalPerMonth
11108
CY2022Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
179817
CY2022Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
182917
CY2022Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
162250
CY2022Q4 us-gaap Contractual Obligation Due In Fourth Year
ContractualObligationDueInFourthYear
46000
CY2022Q4 us-gaap Contractual Obligation Due In Fifth Year
ContractualObligationDueInFifthYear
46000
CY2022Q4 us-gaap Contractual Obligation
ContractualObligation
616984
CY2020Q3 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
19000000
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022 us-gaap Revenues
Revenues
948911
CY2021 us-gaap Revenues
Revenues
824268
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-14238904
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-13098960
CY2022 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
24562
CY2021 us-gaap Cost Of Goods And Services Sold Depreciation And Amortization
CostOfGoodsAndServicesSoldDepreciationAndAmortization
34161
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-714370
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-316755
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
333389
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
361559
CY2022Q4 us-gaap Assets
Assets
14279717
CY2021Q4 us-gaap Assets
Assets
26869927
CY2022 dei Auditor Name
AuditorName
EISNERAMPER LLP
CY2022 dei Auditor Location
AuditorLocation
New York, New York

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
sngx-20221231x10k_htm.xml Edgar Link completed
0001558370-23-005304-index-headers.html Edgar Link pending
0001558370-23-005304-index.html Edgar Link pending
0001558370-23-005304.txt Edgar Link pending
0001558370-23-005304-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sngx-20221231.xsd Edgar Link pending
sngx-20221231x10k.htm Edgar Link pending
sngx-20221231x10k004.jpg Edgar Link pending
sngx-20221231x10k005.jpg Edgar Link pending
sngx-20221231xex21d1.htm Edgar Link pending
sngx-20221231xex23d1.htm Edgar Link pending
sngx-20221231xex31d1.htm Edgar Link pending
sngx-20221231xex31d2.htm Edgar Link pending
sngx-20221231xex32d1.htm Edgar Link pending
sngx-20221231xex32d2.htm Edgar Link pending
sngx-20221231xex4d1.htm Edgar Link pending
sngx-20221231_cal.xml Edgar Link unprocessable
sngx-20221231_def.xml Edgar Link unprocessable
sngx-20221231_lab.xml Edgar Link unprocessable
sngx-20221231_pre.xml Edgar Link unprocessable